Document is current
Any future updates will be listed below
-
Authors
Gruffydd-Jones, Kevin
- License Information
-
More Information
Article History
Received: 6 December 2024
Accepted: 18 March 2025
First Online: 11 April 2025
Change Date: 9 June 2025
Change Type: Update
Change Details: In this article there was a typo in the acknowledgement which should read BTS/NICE/SIGN instead of BTS/NIVCE/SIGN. The original article has been corrected.
Competing interests
: Dr Gruffydd-Jones has spoken on behalf and acted as an advisor to GSK and Astra Zeneca, He was a member of the BTS/NICE/SIGN Guidelines Committee.
